Ashland Inc. (ASH)
NYSE: ASH · Real-Time Price · USD
72.82
+0.35 (0.48%)
Aug 20, 2026, 4:00 PM EDT - Market closed
Ashland Financials Overview
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Revenue Revenue Growth | 1,842 | 1,824 | 2,113 | 2,191 | 2,391 | 2,111 |
Revenue Growth | -1.44% | -13.68% | -3.56% | -8.37% | 13.26% | 4.71% |
Gross Profit Gross Profit Growth | 615 | 612 | 685 | 668 | 830 | 673 |
Operating Income Operating Income Growth | 179 | 168 | 171 | 166 | 310 | 195 |
Net Income Net Income Growth | 52 | -845 | 169 | 178 | 927 | 220 |
Earnings Per Share EPS Growth | 1.15 | -18.37 | 3.35 | 3.32 | 16.52 | 3.59 |
EPS Growth | - | - | 1.05% | -79.93% | 360.14% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Life Sciences Life Sciences Growth | 664 | 641 | 810 | 869 | 815 | 737 |
Personal Care Personal Care Growth | 579 | 577 | 634 | 598 | 678 | 592 |
Specialty Additives Specialty Additives Growth | 503 | 511 | 572 | 600 | 719 | 655 |
Intermediates Intermediates Growth | 136 | 137 | 144 | 185 | 256 | 178 |
Eliminations Eliminations Growth | -39 | -42 | -47 | -61 | -77 | -51 |
Revenue (Total) Revenue (Total) Growth | 1,842 | 1,824 | 2,113 | 2,191 | 2,391 | 2,111 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Cash & Investments Cash & Investments Growth | 440 | 215 | 300 | 417 | 646 | 210 |
Total Debt Total Debt Growth | 1,476 | 1,490 | 1,468 | 1,458 | 1,383 | 2,103 |
Net Cash (Debt) Net Cash Growth | -1,036 | -1,275 | -1,168 | -1,041 | -737 | -1,893 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -22.90 | -27.72 | -23.36 | -19.28 | -13.16 | -31.03 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 291 | 94 | 411 | 243 | -213 | 560 |
Capital Expenditures CapEx Growth | -85 | -98 | -137 | -170 | -113 | -105 |
Free Cash Flow Free Cash Flow Growth | 206 | -4 | 274 | 73 | -326 | 455 |
Free Cash Flow Growth | 543.75% | - | 275.34% | - | - | 550.00% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Gross Margin | 33.39% | 33.55% | 32.42% | 30.49% | 34.71% | 31.88% |
Operating Margin | 9.72% | 9.21% | 8.09% | 7.58% | 12.96% | 9.24% |
Pretax Margin | 6.79% | -44.35% | -1.14% | 7.30% | 8.62% | 6.40% |
Profit Margin | 2.82% | -46.33% | 8.00% | 8.12% | 38.77% | 10.42% |
FCF Margin | 11.18% | -0.22% | 12.97% | 3.33% | -13.63% | 21.55% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 21, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.680 | 1.640 | 1.580 | 1.440 | 1.270 | 1.150 |
Dividend Per Share Growth | 1.83% | 3.80% | 9.72% | 13.39% | 10.44% | 4.54% |
Dividend Yield | 2.31% | 3.50% | 1.91% | 1.88% | 1.45% | 1.42% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 21, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
PE Ratio | 43.93 | - | 25.13 | 23.51 | 5.55 | 24.60 |
Forward PE | 17.77 | 11.06 | 16.40 | 16.03 | 16.41 | 17.18 |
P/FCF Ratio | 16.19 | - | 15.50 | 57.33 | - | 11.90 |
PS Ratio | 1.81 | 1.20 | 2.01 | 1.91 | 2.15 | 2.56 |